Proinsulin serum concentrations in women with polycystic ovary syndrome: A marker of β-cell dysfunction?

Human Reproduction

Volumn 18, Issue 12, 2003, Pages 2683-2688

  Maliqueo, M ^a   Atwater, I ^b   Lahsen, R ^a   Perez Bravo F ^a   Angel, B ^a   Sir Petermann, T ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Polycystic ovary syndrome; Proinsulin; cell function

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; C PEPTIDE; GLUCOSE; INSULIN; PROINSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADIPOSE TISSUE; ADULT; AMENORRHEA; ARTICLE; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HIRSUTISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; OBESITY; OLIGOMENORRHEA; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PANCREAS FUNCTION DISORDER; PANCREAS ISLET CELL FUNCTION; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

FALLOPIA;

EID: 0346147068     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg482     Document Type: Article

References (36)

1. Adams, J., Polson, D.W. and Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J., 293, 355-359.
2. Conway, G.S., Clark, P.M. and Wong, D. (1993) Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin. Clin. Endocrinol. (Oxf.), 38, 219-222.
3. Ciampelli, M., Fulghesu, A.M., Cucinelli, F., Pavone, V., Caruso, A., Mancuso, S. and Lanzone, A. (1997) Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum. Reprod., 12, 1897-1901.
4. Chin, D., Oberfield, E., Silfenn, D., McMahon, D., Manibo, A., Accili, D. and Levine, L. (2002) Proinsulin in girls: Relationship to obesity, hyperinsulinemia, and puberty. J. Clin. Endocrinol. Metab., 87, 4673-4677.
5. Dunaif, A., Segal, K.R., Futterweit, W. and Dobrjansky, A. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165-1174.
6. Dunaif, A. and Fingood, D. (1996) Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 81, 942-947.
7. Ehrmann, D.A., Barnes, R.B. and Rosenfield, R.L. (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr. Rev., 16, 322-353.
8. Ehrmann, D.A., Barnes, R.B., Rosenfield, R.L., Cavaghan, M.K. and Imperial, J. (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care, 22, 141-146.
9. Ferrannini, E. (1998) Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects. Endocr. Rev., 19, 477-490.
10. Franks, S. (1995) Polycystic ovary syndrome. N. Engl. J. Med., 333, 853-861.
11. Gama, R., Norris, F., Wright, J., Morgan, L., Hampton, S., Watkins, S. and Marks, V. (1996) The entero-insular axis in polycystic ovarian syndrome. Ann. Clin. Biochem., 33, 190-195
12. Haffner, S.M., Stern, M.P., Mitchell, B.D., Hazuda, H.P. and Patterson, J.K. (1990) Incidence of Type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes, 39, 283-288.
13. Haffner, S.M., Mykkanen, L., Valdez, R.A., Stern, M.P., Holloway, D.L., Monterrosa, A. and Bowsher, R.R. (1994) Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J. Clin. Endocrinol. Metab., 79, 1806-1810.
14. Haffner, S.M., Miettinen, H., Gaskill, S.P. and Stern, M.P. (1995) Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 44, 1386-1391.
15. Haffner, S.M., Gonzalez, C., Mykkänen, L. and Stern, M. (1997) Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: The Mexico City Diabetes Study. Diabetologia, 40, 830-837.
16. Hanley, A.J., McKeown-Eyssen, G., Harris, S.B., Hegele, R.A., Wolever, T.M., Kwan, J. and Zinman, B. (2002) Cross-sectional and prospective association between abdominal adiposity and proinsulin concentration. J. Clin. Endocrinol. Metab., 87, 77-83.
17. Hull, M.G. (1987) Epidemiology of infertility and polycystic ovarian disease: Endocrinological and demographic studies. Gynecol. Endocrinol., 1, 235-245.
18. Jensen, C.C., Cnop, M., Hull, R.L., Fujimoto, W.Y., Kahn, S.E., American Diabetes Association GENNID Study Group (2002) Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes, 51, 2170-2178.
19. Kahn, S.E., Leonetti, D.L., Prigeon, R.L., Boyko, E.J., Bergstrom, R.W. and Fujimoto, W.Y. (1995) Relationship of proinsulin and insulin with non-insulin-dependent diabetes and coronary heart disease in Japanese American men: Impact of obesity - Clinical research Center study. J. Clin. Endocrinol. Metab., 80, 1399-1406.
20. Knochenhauer, E.S., Key, T.J., Kahsar-Miller, M., Waggoner, W., Boots, L.R. and Azziz, R. (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J. Clin. Endocrinol. Metab., 83, 3078-3082.
21. Legro, R.S., Kunselman, A.R., Dodson, W.C. and Dunaif, A. (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab., 84, 165-169.
22. Matsuda, M. and DeFronzo, R.A. (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care, 22, 1462-1470.
23. Matsumoto, K., Miyake, S., Yano, M., Ueki, Y., Yamaguchi, Y., Akazawa, S. and Tominaga, Y. (1997) Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care, 20, 1562-1568.
24. Mykkänen, L., Haffner, S.M., Kuusisto, J., Pyorala, K., Hales, C.N. and Laakso, M. (1995). Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia, 38, 1176-1182.
25. Mykkänen, L., Haffner, S.M., Hales, C.N., Ronnemaa, T. and Laakso, M. (1997) The relation to proinsulin, insulin and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycaemic subjects. Diabetes, 46, 1990-1995.
26. O'Meara, N.M., Blackman, J.D., Ehrmann, D.A., Barnes, R.B., Jaspan, J.B., Rosenfield, R.L. and Polonsky, K.S. (1993). Defects in beta-cell function in functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab., 76, 1241-1247.
27. Reaven, G.M., Chen, Y.D., Hollenbeck, C.B., Sheu, W.H., Ostrega, D. and Polonsky, K.S. (1993) Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J. Clin. Endocrinol. Metab., 76, 44-48.
28. Roder, M.E., Porte, D. Jr, Schwartz, R.S. and Kahn, S.E. (1998) Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab., 83, 604-608.
29. Roder, M.E., Dinesen, B., Hartling, S.G., Houssa, P., Vestergaard, H., Sodoyez-Goffaux, F. and Binder, C. (1999) Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care, 22, 609-614.
30. Saad, M.F., Kahn, S.E., Nelson, R.G., Pettitt, D.J., Knowler, W.C., Schwartz, M.W., Kowalyk, S., Bennett, H. and Porte, D. Jr (1990) Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab., 70, 1247-1253.
31. Sinha, R., Fisch, G., Teague, B., Tamborlane, W.V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., Sherwin, R.S. and Caprio, S. (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N. Engl. J. Med., 346, 802-810.
32. Stumvoll, M., Mitrakou, A., Pimenta, W., Jenssen, T., Yki-Jarvinen, H., Van Haeften, T., Renn, W. and Gerich, J. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care, 23, 295-301.
33. Wareham, N.J., Byrne, C.D., Williams, R., Day, N.E. and Hales, C.N. (1999) Fasting proinsulin concentrations predict the development of Type 2 diabetes. Diabetes Care, 22, 262-270.
34. Williams, D.R., Byrne, C., Clark, PM., Cox, L., Day, N.E., Rayman, G., Wang, T. and Hales, C.N. (1991) Raised proinsulin concentration as early indicator of beta cell dysfunction. Br. Med. J., 303, 95-96.
35. World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation, Part I: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva.
36. Zawadzki, J.K. and Dunaif, A. (1992) Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In Hershmann, J.M. (ed.), Current Issues in Endocrinology and Metabolism. Blackwell, Boston, pp. 377-384.